These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38272517)
1. Subsequent development of Kawasaki disease following acute human adenovirus infection among siblings. Sankannaavr A; Puttalinga D; Bagalkot PS BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272517 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case report. Fukuda S; Ito S; Fujiwara M; Abe J; Hanaoka N; Fujimoto T; Katsumori H Pediatr Rheumatol Online J; 2017 May; 15(1):39. PubMed ID: 28511718 [TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report. Yu X; Liu X; Wang Y; Lu N; Wang M; Sun L Medicine (Baltimore); 2019 Feb; 98(7):e14395. PubMed ID: 30762741 [TBL] [Abstract][Full Text] [Related]
4. A Sri Lankan infant with immunoglobulin resistant incomplete Kawasaki disease with a vesicular psoriasiform rash, hypertension and late onset small joint arthritis: a case report. Hoole TJ; Athapathu AS; Abeygunawardene AD BMC Pediatr; 2022 Jul; 22(1):444. PubMed ID: 35870915 [TBL] [Abstract][Full Text] [Related]
5. Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes. Jaggi P; Grcic M; Kovalchin J; Wilhelm CM; Yildirim-Toruner C; Texter K J Pediatric Infect Dis Soc; 2018 May; 7(2):119-123. PubMed ID: 28383697 [TBL] [Abstract][Full Text] [Related]
6. Nontypical presentation of a common disease: a case report. Alshammasi W; Bargawi A; Abdulrahman A; Alhaji M; Al Qahtani F; Aldajani A J Med Case Rep; 2022 Jan; 16(1):11. PubMed ID: 35022064 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm. Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865 [TBL] [Abstract][Full Text] [Related]
8. [Clinical experience in the treatment of incomplete Kawasaki disease with no response to intravenous immunoglobulin: a case report]. Yang ZY; Liu JY; Yan XP; Jiao FY Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1311-1312. PubMed ID: 36544409 [TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms. Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995 [TBL] [Abstract][Full Text] [Related]
10. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. Tse SM; Silverman ED; McCrindle BW; Yeung RS J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960 [TBL] [Abstract][Full Text] [Related]
11. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report. Raut S; Roychowdhoury S; Bhakta S; Sarkar M; Nandi M J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32756980 [TBL] [Abstract][Full Text] [Related]
12. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease. Chen J; Liu P; Hu W; Xu Y; Deng J Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986 [TBL] [Abstract][Full Text] [Related]
13. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol. Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139 [TBL] [Abstract][Full Text] [Related]
14. A 3-month-old infant with atypical Kawasaki disease. Lertamornkitti N; Wangjirapan A BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29848518 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroids for the treatment of Kawasaki disease in children. Wardle AJ; Connolly GM; Seager MJ; Tulloh RM Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011188. PubMed ID: 28129459 [TBL] [Abstract][Full Text] [Related]